InfanDx receives U.S. patent for its core technology on diagnosis of neonatal encephalopathy

Newron announces initiation of new clinical trial with Evenamide in patients with schizophrenia, following approval of plan by FDA

Karl Naegler joins Wellington Partners as Managing Partner

Expedeon AG: Expedeon AG and Abcam plc close EUR 120 million transaction